These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 9539409)
1. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years. Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Bickeböller H; Campion D; Brice A; Amouyel P; Hannequin D; Didierjean O; Penet C; Martin C; Pérez-Tur J; Michon A; Dubois B; Ledoze F; Thomas-Anterion C; Pasquier F; Puel M; Demonet JF; Moreaud O; Babron MC; Meulien D; Guez D; Chartier-Harlin MC; Frebourg T; Agid Y; Martinez M; Clerget-Darpoux F Am J Hum Genet; 1997 Feb; 60(2):439-46. PubMed ID: 9012418 [TBL] [Abstract][Full Text] [Related]
3. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757 [TBL] [Abstract][Full Text] [Related]
5. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran. Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Chen Q; Wang T; Kang D; Chen L Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease. Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772 [TBL] [Abstract][Full Text] [Related]
8. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Agarwal R; Tripathi CB Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665 [TBL] [Abstract][Full Text] [Related]
11. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E type epsilon4 allele, heritability and age at onset in twins with Alzheimer disease and vascular dementia. Bergem AL; Lannfelt L Clin Genet; 1997 Nov; 52(5):408-13. PubMed ID: 9520135 [TBL] [Abstract][Full Text] [Related]
13. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Drigalenko E; Poduslo S; Elston R Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492 [TBL] [Abstract][Full Text] [Related]
15. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Payami H; Zareparsi S; Montee KR; Sexton GJ; Kaye JA; Bird TD; Yu CE; Wijsman EM; Heston LL; Litt M; Schellenberg GD Am J Hum Genet; 1996 Apr; 58(4):803-11. PubMed ID: 8644745 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample. Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755 [TBL] [Abstract][Full Text] [Related]
17. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset. Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238 [TBL] [Abstract][Full Text] [Related]
18. Increased CSF cortisol in AD is a function of APOE genotype. Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. Evans DA; Beckett LA; Field TS; Feng L; Albert MS; Bennett DA; Tycko B; Mayeux R JAMA; 1997 Mar; 277(10):822-4. PubMed ID: 9052713 [TBL] [Abstract][Full Text] [Related]
20. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]